ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ProBioGen Was Granted a New Patent for DirectedLuck® Transposase Technology
January 17, 2024ProBioGen announced today that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck® technology. -
Asher Bio, ProBioGen Ink Development, Mfg. Agreement
April 27, 2021ProBioGen to provide cell line development, process development and GMP manufacturing at 1000 L bioreactor scale of Asher's lead immuno-oncology candidate. -
DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development
November 13, 2019ProBioGen AG, a premier German service & technology provider for complex biologics, announced the launch of DirectedLuck, a highly active transposase equipped for specific epigenetic targeting.
Pharma Sources Insight January 2025
